Professional Documents
Culture Documents
MULTIPLE CHOICE
1. The branch of pharmacology that addresses drug amounts at various sites in the body after
drug administration is called
a. pharmacodynamics.
b. pharmacokinetics.
c. pharmacotherapeutics.
d. pharmacy.
ANS: B REF: p. 202
4. The decrease in blood clotting by heparin occurs at which general site of action?
a. Cellular
b. Extracellular
c. Neuromuscular
d. Intracellular
ANS: B REF: p. 205
6. All of the following are ways the kidney are used for urine formation and drug clearance
except
a. Filtration
b. Tubular secretion
c. Tubular filtration
d. Tubular reabsorption
ANS: C REF: p. 207
9. A subacute toxic effect occurs when the adverse drug effect occurs
a. after 5 minutes of exposure.
b. after 24 hours of exposure.
c. after repeated exposure for days.
d. over months to years of exposure.
ANS: C REF: p. 209
11. The term used to indicate the extent to which a drug reaches its site of action is
a. bioactivity.
b. bioavailability.
c. bioremediation.
d. biostasis.
ANS: B REF: p. 205
12. Drugs needed for diseases with fewer than 200,000 patients, and that fail to receive attention
for development because of cost and need, are called
a. secondary drugs.
b. minor drugs.
c. orphan drugs.
d. specialty drugs.
ANS: C REF: p. 211
13. The discipline addressing issues associated with the choice and application of drugs to be used
for disease prevention, treatment, and/or diagnosis is
a. pharmacotherapeutics.
b. toxicology.
c. pharmacokinetics.
d. pharmacy.
ANS: A REF: p. 202
14. Drugs are excreted from the body primarily via the
a. lungs.
b. kidneys.
c. small intestines.
d. spleen.
ANS: B REF: p. 206
COMPLETION
ANS: biotransformation
REF: p. 205
2. The study of the body’s response to poisons and their harmful effect is referred to as
__________.
ANS: toxicology
REF: p. 209
ANS: pharmacokinetics
REF: p. 204
ANS: dose
REF: p. 207
5. The federal agency that approves the use of a specific drug is the __________.
ANS: FDA
REF: p. 211
6. The three general sites of drug action are __________, __________, and __________.
ANS:
extracellular, cellular, intracellular
extracellular, intracellular, cellular
cellular, extracellular, intracellular
cellular, intracellular, extracellular
intracellular, cellular, extracellular
intracellular, extracellular, cellular
REF: p. 205
7. The __________ effect is the combined action of intestinal and hepatic drug-metabolizing
enzymes that affects a drug’s bioavailability.
ANS: first-pass
REF: p. 208
8. A __________ name is a nonproprietary single name usually related to the drug’s relationship
to a therapeutic class.
ANS: generic
REF: p. 203
9. Drugs and substances with a high probability for abuse with no therapeutic use and a lack of
safety controls are classified as Schedule __________.
ANS: I
REF: p. 211
10. The __________ is the ratio between a drug dose causing undesirable effects and the dose
that causes the desired effects.
REF: p. 207
MATCHING
Match the description below with the correct item from this list.
a. Morphine
b. Administered into the subarachnoid space
c. Diazepam
d. Administered into muscles
e. Aspirin
f. Administered sublingually
g. L-Dopa
h. LSD
1. Prodrug
2. Schedule II controlled substance
3. Intrathecally
4. Schedule I controlled substance
5. Schedule IV controlled substance